Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Immunogenicity and Efficacy of a Measles Virus-vectored Chikungunya Vaccine in Nonhuman Primates.

Rossi SL, Comer JE, Wang E, Azar SR, Lawrence WS, Plante JA, Ramsauer K, Schrauf S, Weaver SC.

J Infect Dis. 2019 May 3. pii: jiz202. doi: 10.1093/infdis/jiz202. [Epub ahead of print]

PMID:
31053842
2.

Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.

Comer JE, Escaffre O, Neef N, Brasel T, Juelich TL, Smith JK, Smith J, Kalveram B, Perez DD, Massey S, Zhang L, Freiberg AN.

Viruses. 2019 Feb 3;11(2). pii: E137. doi: 10.3390/v11020137.

3.

Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection.

Ekins S, Lingerfelt MA, Comer JE, Freiberg AN, Mirsalis JC, O'Loughlin K, Harutyunyan A, McFarlane C, Green CE, Madrid PB.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01711-17. doi: 10.1128/AAC.01711-17. Print 2018 Feb.

4.

Modeling Rabbit Responses to Single and Multiple Aerosol Exposures of Bacillus anthracis Spores.

Coleman ME, Marks HM, Bartrand TA, Donahue DW, Hines SA, Comer JE, Taft SC.

Risk Anal. 2017 May;37(5):943-957. doi: 10.1111/risa.12688. Epub 2017 Jan 25.

5.

First vaccine approval under the FDA Animal Rule.

Beasley DWC, Brasel TL, Comer JE.

NPJ Vaccines. 2016 Aug 25;1:16013. doi: 10.1038/npjvaccines.2016.13. eCollection 2016.

6.

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

Mytle N, Hopkins RJ, Malkevich NV, Basu S, Meister GT, Sanford DC, Comer JE, Van Zandt KE, Al-Ibrahim M, Kramer WG, Howard C, Daczkowski N, Chakrabarti AC, Ionin B, Nabors GS, Skiadopoulos MH.

Antimicrob Agents Chemother. 2013 Nov;57(11):5684-92. doi: 10.1128/AAC.00458-13. Epub 2013 Aug 26.

7.

Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques.

Henning LN, Comer JE, Stark GV, Ray BD, Tordoff KP, Knostman KA, Meister GT.

Clin Vaccine Immunol. 2012 Nov;19(11):1765-75. doi: 10.1128/CVI.00288-12. Epub 2012 Sep 5.

8.

Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit model.

Barnewall RE, Comer JE, Miller BD, Gutting BW, Wolfe DN, Director-Myska AE, Nichols TL, Taft SC.

Front Cell Infect Microbiol. 2012 Jun 13;2:71. doi: 10.3389/fcimb.2012.00071. eCollection 2012.

9.

Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment.

Comer JE, Ray BD, Henning LN, Stark GV, Barnewall RE, Mott JM, Meister GT.

Clin Vaccine Immunol. 2012 Sep;19(9):1517-25. doi: 10.1128/CVI.00292-12. Epub 2012 Jul 25.

10.

Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.

Comer JE, Sturdevant DE, Carmody AB, Virtaneva K, Gardner D, Long D, Rosenke R, Porcella SF, Hinnebusch BJ.

Infect Immun. 2010 Dec;78(12):5086-98. doi: 10.1128/IAI.00256-10. Epub 2010 Sep 27.

11.

Examining the vector-host-pathogen interface with quantitative molecular tools.

Comer JE, Lorange EA, Hinnebusch BJ.

Methods Mol Biol. 2008;431:123-31.

PMID:
18287752
12.

Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.

Peterson JW, Comer JE, Baze WB, Noffsinger DM, Wenglikowski A, Walberg KG, Hardcastle J, Pawlik J, Bush K, Taormina J, Moen S, Thomas J, Chatuev BM, Sower L, Chopra AK, Stanberry LR, Sawada R, Scholz WW, Sircar J.

Infect Immun. 2007 Jul;75(7):3414-24. Epub 2007 Apr 23.

13.

Murine macrophage transcriptional and functional responses to Bacillus anthracis edema toxin.

Comer JE, Galindo CL, Zhang F, Wenglikowski AM, Bush KL, Garner HR, Peterson JW, Chopra AK.

Microb Pathog. 2006 Aug-Sep;41(2-3):96-110. Epub 2006 Jul 18.

PMID:
16846716
14.

Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.

Peterson JW, Comer JE, Noffsinger DM, Wenglikowski A, Walberg KG, Chatuev BM, Chopra AK, Stanberry LR, Kang AS, Scholz WW, Sircar J.

Infect Immun. 2006 Feb;74(2):1016-24.

15.

Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo.

Comer JE, Chopra AK, Peterson JW, König R.

Infect Immun. 2005 Dec;73(12):8275-81.

16.

Glycosylation substrate specificity of Pseudomonas aeruginosa 1244 pilin.

Horzempa J, Comer JE, Davis SA, Castric P.

J Biol Chem. 2006 Jan 13;281(2):1128-36. Epub 2005 Nov 11.

17.
18.

Plasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmission.

Li F, Templeton TJ, Popov V, Comer JE, Tsuboi T, Torii M, Vinetz JM.

J Biol Chem. 2004 Jun 18;279(25):26635-44. Epub 2004 Apr 6.

19.

Novel Immunoreactive glycoprotein orthologs of Ehrlichia spp.

McBride JW, Comer JE, Walker DH.

Ann N Y Acad Sci. 2003 Jun;990:678-84.

PMID:
12860706
20.

Identification of the Pseudomonas aeruginosa 1244 pilin glycosylation site.

Comer JE, Marshall MA, Blanch VJ, Deal CD, Castric P.

Infect Immun. 2002 Jun;70(6):2837-45.

Supplemental Content

Loading ...
Support Center